ConductScience.org, home

Paper398688

Daunorubicin reductase activity in leukemia leukocyte homogenates.

Gola A. Arch Immunol Ther Exp (Warsz), 1979. Cited by 8 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Daunorubicin reductase activity in leukemia leukocyte homogenates. Papers, record 398688. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/398688

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Daunorubicin reductase activity in leukemia leukocyte homogenates.
PubMed
Journal
Arch Immunol Ther Exp (Warsz)
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.45
iCite
Revised in PubMed
2017-11-17
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gola AA

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alcohol OxidoreductasesMajor topic
DaunorubicinMajor topic
LeukemiaMajor topic
LeukocytesMajor topic
Adolescent
Adult
Aldehyde Reductase
Aldo-Keto Reductases
Female
Humans
Male
Middle Aged

Source PubMed

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
6,961,971Uptake and metabolism of daunorubicin by human leukemia cells.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/6961971PubMed
6,958,392Metabolism of daunorubicin in sensitive and resistant Ehrlich ascites tumor cells. Determination by high pressure liquid chromatography.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/6958392PubMed
6,488,444Kinetics and sensitivity of daunorubicin in patients with acute leukemia.Cancer Chemother Pharmacol1984https://conductscience.org/library/papers/6488444PubMed
3,539,383Contribution of drug transport and reductases to daunorubicin resistance in human myelocytic cells.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3539383PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
AKR1A110,327PubTator's text mininghttps://conductscience.org/library/genes/10327

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/398688

GET https://conductscience.org/api/papers/v1/398688/authors